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ABSTRACT: ‘Yogaraj and Laxadi guguly’ are two Ayurvedic medicine has been tried clinically 
on 12 patients for the maintenance of haemoglobine level and prevention of repeated blood 
transfusion in sicklecell disorders, the duration of  treatment was 3 month. Pathological 
investigations were conducted periodically during the administration of medicine. The patients 
were examined clinically every month to note the effect of reducing fever, weakness, enlargement 
of spleen and liver which are statistically significant.  The Hb gm% was gradually increased in 
the treated patient which is also statistically significant, But not required since 1 yr. from the 
date of research. Thus the study proves that the administration of indigenous medicine with folic 
acid is beneficial in restoring the blood Hb gm% than that of only folic acid. 
 
INTRODUCTION  
 
The human Red blood cells (RBC) are 
circular biconcave and the diameter of the 
center is less than periphery.  In certain 
condition when circular RBCs under gone 
sickle form due to abnormal posting of 
certain amino acid in B chain of adult 
haemoglibin A1, the diseases known as 
sickle cell diseases or sickle cell disorders 
(SCD). Sickle cell disorders mainly included 
sickle cell anemia (SCA) sickle cell trait 
(SCT), sickle B thalassemia, and sickle C 
disease, sickle D disease and sickle E 
disease.  Sickle cell anemia (12- 15%) sickle 
cell trait (80-85%) and sickle B thalassemia 
(2-3%) diseases are commonly seen in hilly 
areas of Orissa specially in the district of 
kalahandi (16%), Sambalpur (17%), 
Sundargarh (15%) and bolongir (15%) 
population. 
 
The clinical features of sickle cell disorders 
have got maximum resemblance with 
Raktadusti (Jeerna Jwara, Hepatomegaly, 
Splenomegaly) rather than pandu Roga as 
described in compendiums of Ayurvedic 
system of medicine. Hence the diseases in 
combination may be mentioned as a 
syndrome for sickle cell disorders. 
 
MATERIALS AND METHODS  
 
The clinical study was done as per the 
following procedure given below: 
 
(a) Selection of Patients 
 
Twelve sickle cell disorder patients of 
different age groups ranging 3 to 18 years of 
both sex complain with mild fever, anemia 
(Haemoglobin 5 to 8 gm%) hepatomegaly, 
muscular pain in both extremities those who 
were advised for frequent blood transfusion 
and coverage of anti inflammatory drugs 
were selected for clinical study.  All the 
patients were advised to attain 30 days 
interval regularly for 3 months. During the 
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follow up time all the investigations were 
also repeated. 
 
(b) Selection of Drugs: 
 
The drugs (Medicine) Yogaraj has classical 
references and used as hepato protecting 
action, blood purifier, decreasing in 
hepatosplenomegaly and chronic fever, 
which as a whole helps in pitta vicars. As 
the haem part of haemoglobin is intact so 
Lauha bhasma was not mixed with in order 
to avoid haem overload, Lakshyadi gugulu 
is used as best bone unioner which also to 
reduce pain (Vitiated vayu) inside bone 
marrow and helps in erythropoisis. As sickle 
cell disorders are due to vitiation of vayu & 
pitta. So these two drugs help to stable the 
above doshas. 
 
Patient were treated with Lakshyadi gugulu 
after food with warm water and Yogaraj 
with honey.  Punarnava (Barrhevia difusa) 
swarasa and sarapunkha (Theprosia 
purpuris) swarasa ½ tsf is with the dosage of 
2 Gm. & 250 Mg twice daily respectively 
for 3 months. Patient below 10 years 
reveived half of the schedule drug dose with 
above anupans. 
 
The preparation of medicines were as 
prescribed in vaisajyaratna in combination 
with indigenous medicines, folic acid 
(Folate) 5 gm once daily is supplemented 
through our the study period in order to help 
in erythropoisis. 
 
(c) Parameter of Investigations: 
 
Estimation of haemoglobin (sahils method) 
and ESR (Western green method), sickling 
test (24 hour method) and peripheral blood 
picture were the investigation procedure for 
diagnosis of sickle cell disorder patients, 
haemoglobin  electrophoresis was not 
available near by so the confirm division of 
sickle cell disorders could not be done. 
 
(d) Parameter of Assessment of Progress: 
 
The symptoms (fever, weakness, abdominal 
discomfort and pain in extremities) observed 
during follow up period was separated by 
grading 0,1,2,3, on the basis of seventy and 
duration.  The improvement was conferment 
from favourable shift grade of each sign and 
symptoms and haemoglobin gm% from 3-0. 
 
The sign (hepato splenomegaly) and 
haemoglobing were measured in and gm% 
respectively in every follow up period. 
 
(e) Parameter of Responses: 
 
In view of percentage of relief it was 
declared in the language as follows: 
 
(a) Response: 
 
-No clinical features of hemolytic anemia 
- Hemoglobin above 8gm% 
-Sickling test positive 
 
(b) Partial response: 
 
-Mild to moderate features of hemolytic 
anemia 
-Hemoglobin within 6-8gm% 
-Sickling test positive 
 
(c) No response: 
 
-  Feature of haemolytic anemia as 
seen before treatments or persisted  
-  Haemoglobin below  6gm% 
-  Sickling test positive 
 
(f) Ayurvedic material and methods for 
study: 
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Ayurveda emphasizes on prajkriti (Vattik, 
Paittik, shlesmic, Dwandaja and tridoshas), 
dosha, dushya adhistan Desha and Kala as 
diagnosis procedures of different diseases. 
Patients were also analyzed according to the 
above ayurvedic concepts. 
 
Table No 1. 
Ingredients of YogaRaj 
 
Name of the Drug No  Quantity 
1.  Haritaki 
2.  Bibhitaki 
3.  Trikatu 
4.  Bidanga 
5.  Sidguta sgukajatu 
6.  Swarnamakshika 
7.  Rajatmakshika 
8.  Mishri 
9.  Madhu 
1Part 
1Part 
1Part each 
! Part 
5 Part 
5 Part 
5 Part 
8 Part 
Q.S. 
 
Table No 2. 
Ingredients of Laxadi Gugulu 
 
Name pf the drug 
No 
Latin Name  Quantity 
1. Lakshya 
2. Asthisamhari  
3. Arjun 
4. Aswagandha 
5. Nagabala 
6. Gugulu 
Rosa centifolia  
Cissus Quadrangularis 
Terminalia arjuna 
Withina somnifera 
Grewia hirsute 
Commiphora mukul  
1part  
1part 
1part 
1part 
1part 
5part 
 
Table No 3. 
Signs and Symptoms 
 
Clinical features  No of cases  Percentage 
Symptoms: 
1.  Abdominal discomfort 
2.  Pain extremities 
3.  Weakness 
4.  Fever 
Sign: 
1.  Splenomegaly 
2.  Hepatomegaly 
3.  Bony tenderness 
4.  Yellowish eye 
5.  Pallor 
 
4 
11 
11 
11 
 
11 
11 
5 
3 
12 
 
33% 
91% 
91% 
91% 
 
91% 
91% 
42% 
25% 
100% 
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Table No 4 
Mean and SD value of symptoms in 12 Sickle cell disorder patients 
 
Symptoms Grade  BT  AT 
Fever 0 
1 
2 
3 
Mean ± SD 
0 
2 
9 
1 
1.08 ±0.5 
0 
1 
1 
10 
Mean 0.25 ±SD 0.59 
Weakness 0  0  0 
 
 
 
Mean ± SD 
1 
2 
3 
8 
3 
1 
1.58 ±0.48 
2 
6 
4 
0.83 ± 0.69 
Pain in extremities       
 
 
 
 
Mean ± SD 
Abdominal  
Discomfort 
0 
1 
2 
3 
 
0 
1 
2 
3 
Mean ± SD 
2 
3 
6 
1 
1.58±0.71 
0 
2 
2 
8 
0.41 ± 0.81 
1 
1 
2 
8 
0.58 ± 0.59 
0 
1 
1 
10 
0.25 ± 0.59 
 
Table No 5. 
Mean and SD value of Liver and spleen in 12 patients 
 
Case No  Liver  BT 
gnem 
Spleen At gnem  BT  AT 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10 
11. 
12. 
Mean ± 
SD 
6 
4.5 
5 
0 
0 
0.5 
3 
3 
3 
5 
0 
6.5 
2.6 
±2.36 
4 
2 
2 
0 
0 
0 
2.5 
2 
2 
0 
0 
2 
1.37 
±1.28 
5 
7.5 
7.5 
3 
2.5 
0.5 
9 
5 
3 
0 
3 
6 
4.3 
±2.53 
2 
4 
5.5 
1 
2.5 
0 
6 
1 
2 
0 
1 
3 
2.3 
±1.93 
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Table No.6 
The Heamoglobin value of 12 patients (Mean ± SD) 
 
Case No  BT  AT 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10 
11. 
12. 
Mean 
± SD 
6.6 
6.4 
5.4 
5.5 
6.4 
6.6 
7.2 
6.9 
7.5 
7.2 
6.5 
8.0 
6.6 
±0.78 
6.8 
10.2 
5.9 
6.2 
8.0 
9.2 
9.0 
7.7 
9.0 
8.5 
9.4 
10.5 
8.36 
±1.46 
 
BT = Before treatment  
AT= After treatment  
 
DISCUSSION  
 
Recently, Blood transfusion is the ideal 
procedure to maintain haemoglobin gm% 
and to save life sickling patient but the 
administration of indigenous drugs help to 
avoid recurrent blood transfusion, 
minimizing the clinical findings and 
increase the haemoglobin gm% in blood 
picture, the present siuty infeerrent that the 
maximum patients were selcted within the 
atge of qo0 to 15 years the patients those 
who had received more than -5 times blood 
transfusion, their liver and spleen were 
enlearged more than 4 cm. But after 
receiving the trial medicines the 
enlargement of liver n spleen fo those 
patients were gradually reduced, most of the 
patient were the complaints o fever (91%), 
weakness (91%) and pain in extremities 
(19%) alongwith heaptosplenomegaly. 
 
In continuation of indigenous medicine 
yogaRaj and Laxadi gugulu with folic acid 
for Ist 30 days, improvement was less 
obnserved and subsequentlyl improvement 
was recorde with reducing fever, weakness, 
enlargement of spleen and liver ewhich are 
staisticallyy significant, the clinical 
improvement in reducing pain in extremities 
wer marked but statistically the effect of the 
medicine was not signigicant . a like, the 
haemoglobin gm% was gradually increased 
in the treated patient swhich is also 
statistically diginifcant. But the morphology 
and sickle cell phemomean in peripheral 
blood smera wer unchanged, further blood 
transfusion was not required since one year 
form the date of research. Thus the study 
proves that the administration of indigenous 
medicine with folic acid is bebefical in 
restoring the blood haemoglobin gm% than 
the at of only folic acid. Out of twelve, tow 
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patients were with the symptoms fo 
anorexia.  Constitpatiion and jaundice, after 
10 days of treatment the appetite of the 
patients was increased and bowel was 
cleared but jaundice was still persisted, 
being vigilantto the sickle cell condition and 
sincere to the treatment of jaundice the 
prescibede sose of indigenous medicine 
except thefolic acid was reduced to helf of 
full dose and prophylactic &^ curative 
hepatoprotective drug (Liv 52 2 tab TDS) 
was administered for a period of two weeks 
and janudic was gradually reduced.  So on 
the basis of clinical and investiagioin 
findings, it si inferred tha the indigenous 
medicine yogaRaj and Laxadi Gugulu may 
be used as an adjuvant teerapy in 
combination with folic acid for the treatment 
of sickle sell disorder patients.  However 
this is a preliminary study further detail stiy 
in required to establish the effectiveness of 
indigenous drugs. 
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